People with Asthma Should Take Extra Precautions During COVID-19
Montreal researchers testing potential COVID-19 treatment with steroid inhaler | CTV News
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective | European Respiratory Society
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
Asthma and COVID-19 Vaccines — Answers to Your Top Questions
Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage | Journal of Pharmaceutical Policy and Practice | Full Text
Does asthma raise Covid-19 risk? Research points to complex connection
A message to asthma sufferers about a shortage of albuterol metered dose inhalers - ACAAI Public Website
Here's why people with allergic asthma are at lower COVID-19 risk | Science News
Inhalable COVID-19 vaccine could expand the reach of COVID-19 vaccines around the world - Northeastern Global News
Is Asthma Tx a Breath of Fresh Air for Early COVID-19 Patients? | MedPage Today
Biomedicines | Free Full-Text | Post-COVID-19 Symptoms in Adults with Asthma—Systematic Review
Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests | University of Oxford
Asthma inhalers being trialed for treatment of COVID-19
Please Don't Stop Your Asthma Medicines – An Editorial From Dr. Mitchell Grayson on the Coronavirus (COVID-19) | Asthma and Allergy Foundation of America
Blood type not a COVID-19 risk factor in U.S.; inhaled asthma drug may keep mild illness from worsening | Reuters
Inhaled corticosteroids fail to protect against COVID-19-related death in asthma, COPD
Asthma drug may reduce risk of severe Covid if taken early – study | Coronavirus | The Guardian
QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19
COVID-19 and Asthma What You Need to Know | University Hospitals
Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR